RD Badania Kliniczne Sp. z o.o.

What RD Badania Kliniczne Sp. z o.o. does

RD Badania Kliniczne Sp. z o.o. is a privately held Polish limited liability company (Sp. z o.o.) founded in 2018 and registered in Warsaw (KRS 0000712621), operating as an independent professional publisher for the Polish clinical research industry. The company produces the quarterly journal Badania Kliniczne (Clinical Research), which it distributes in print via Polish Post and in digital form through its website badaniaklinicznepolska.pl. It has maintained a quarterly publication cadence continuously from issue 1/2018 through at least issue 2/2026.

The product portfolio centers on three revenue streams. First, annual and multi-year journal subscriptions (Prenumerata) sold in PLN via bank transfer on proforma invoices, with both print and electronic formats. Second, the Baza Ośrodków Badań Klinicznych, a searchable online directory of more than 100 Polish clinical trial centers, with free basic listings and paid Premium (219 PLN one-time) and Premium+ (590 PLN/year) tiers that add highlighted placement, active website links, contact details, and rotating banner advertising. Third, a free electronic newsletter delivered via MailerLite, plus gated premium articles and an E-wydania electronic-issues archive accessible to subscribers.

The customer base spans clinical trial professionals (CRAs, coordinators, investigators) and clinical trial centers as primary segments, with secondary audiences in medical professionals and patients/patient advocacy groups. Distribution is single-country, focused on Poland, with limited international delivery of the print edition. Go-to-market is content-led: the journal, the website, the newsletter, and media patronage at industry conferences drive awareness, while database listings and journal subscriptions convert that attention into recurring revenue. The company holds no patents, has no disclosed institutional funding, no disclosed management team, and no disclosed headcount, and its competitive position rests on its editorial archive, its two-sided trial-center database, and its established relationships with industry associations (POLCRO, GCPpl, INFARMA, PZPPF), the Polish Development Fund, and the Ministry of Health.

Name

RD Badania Kliniczne Sp. z o.o.

Legal name

RD Badania Kliniczne Sp. z o.o.

Website

https://badaniaklinicznepolska.pl

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

RD Badania Kliniczne Sp. z o.o. is a Polish independent publisher founded in 2018 that produces the quarterly Badania Kliniczne journal and a searchable database of Polish clinical trial centers, serving clinical research professionals, trial sites, sponsors, and patient advocacy groups via print, digital, and newsletter channels.

Ownership category

akta.pro rank

Product category

Trade Publishing

NAICS

Periodical Publishers (513120)

SIC

Periodicals: Publishing Or Publishing & Printing (2721)

akta.pro industry

PRIMARYEDAGAFAB

Medical, Clinical & Biomedical Scholarly Publishing

Education/Educational Publishing & Learning Content/Academic & Scholarly Publishing (Journals, Monographs)

SECONDARYMPAJABAD

STM Publishing (Science, Technical & Medical)

Media, Entertainment & Sports/Publishing (Books, News, Magazines)/Educational & Academic Publishing (Textbooks, Scholarly, STM)

Keywords

• Clinical trials publishing
• Professional journal publishing
• Subscription services
• Clinical research database
• Industry news media

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Magazine Subscriptions: Sale of quarterly professional journal subscriptions in both print and electronic formats. Customers pay for annual or multi-year subscriptions of the Badania Kliniczne journal covering clinical trials industry topics.
2. Online Content Access: Free access to selected articles and content with premium content available to subscribers. Some articles require subscription to access full content.
3. Clinical Trial Center Database Listing: Paid premium listings for clinical trial centers in their online database, with basic free listings and paid Premium and Premium+ tiers.

Pricing tiers

Distribution channels3 records

Marketing channels5 records

Core offering

RD Badania Kliniczne Sp. z o.o. publishes the quarterly professional journal "Badania Kliniczne" (Clinical Trials) for the Polish clinical research industry, available in print and electronic formats via annual subscription. The company also operates a searchable online database of Polish clinical trial centers with tiered paid listings, and distributes industry news through a free electronic newsletter and online article portal.

Product overview

RD Badania Kliniczne Sp. z o.o. operates as a professional publishing company producing the Badania Kliniczne quarterly journal for clinical research professionals in Poland. The core offering is the journal itself, available via annual subscription (prenumerata) in both print and electronic formats. Supporting products include a searchable database of Polish clinical trial centers (Ośrodki Badań Klinicznych) with tiered subscription options, a free electronic newsletter, and access to electronic article versions through the e-wydania service.

Differentiator

Problem solved

Functional benefit

Products and services

• Badania Kliniczne (Clinical Trials Journal) A quarterly professional trade journal for clinical research professionals in Poland, covering clinical trial methodology, regulations (EU Regulation 536/2014, GDPR), ethics, industry best practices, and interviews with key opinion leaders. Available in both print and electronic subscription formats.
• Prenumerata (Subscription Service) Annual subscription service providing access to quarterly issues of the Badania Kliniczne journal in printed and/or electronic formats, with bank transfer payment via proforma/VAT invoice.
• Baza Ośrodków Badań Klinicznych (Clinical Trial Centers Database)

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• POLCRO (Polski Związek Pracodawców Firm Prowadzących Badania Kliniczne na Zlecenie)coreStrategic or Co-development PartnerPartnership with the Polish Association of CROs. POLCRO collaborated with other organizations to create COVID-19 clinical practice guidelines, demonstrating close working relationship in industry standards development.
• GCPpl (Stowarzyszenie na Rzecz Dobrej Praktyki Badań Klinicznych w Polsce)coreStrategic or Co-development PartnerPartnership with the Polish Good Clinical Practice Association. GCPpl participated in joint initiatives including COVID-19 clinical trial guidelines development.
• INFARMA (Związek Pracodawców Innowacyjnych Firm Farmaceutycznych)coreStrategic or Co-development PartnerPartnership with the Association of Innovative Pharmaceutical Employers. INFARMA collaborated on COVID-19 guidelines and policy initiatives including proposals for government rescue packages.
• PZPPF (Polski Związek Pracodawców Przemysłu Farmaceutycznego)minorStrategic or Co-development PartnerPartnership with the Polish Union of Pharmaceutical Industry Employers, mentioned as collaborating organization in clinical trials education initiatives.
• Polish Development Fund (PFR)coreStrategic or Co-development PartnerPartnership in the Biotechnology Development Program. PFR coordinated efforts to improve clinical trial information access for Polish patients, involving patient foundations and Ministry of Health.
• Ministry of Health (Poland)coreStrategic or Co-development PartnerGovernment partnership for clinical trial information initiatives. Ministry worked with PFR and patient organizations on the Patient-Friendly Clinical Trials campaign.
• Patient Organizations (Fundacja Urszuli Jaworskiej, Polska Unia Organizacji Pacjentów)minorStrategic or Co-development PartnerPartnership with patient advocacy groups for the Patient-Friendly Clinical Trials campaign to improve patient access to clinical trial information.
• Office for Registration of Medicinal Products (URPL)minorStrategic or Co-development PartnerPartnership with the Polish regulatory authority for clinical trials, collaborating on patient education initiatives about clinical research.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Citeline (Pharma Intelligence): Provider of clinical trials intelligence, trial site databases, and industry news targeting sponsors, CROs, and clinical research professionals. Comparable as a direct peer offering paid clinical trial databases, trial site listings, and professional content for the clinical research ecosystem.
• CenterWatch: US-based clinical trials information provider publishing directories of trial sites, sponsor/CRO listings, and industry intelligence. Comparable as a direct peer operating a clinical trial center database with paid listings, professional journal content, and CRO/sponsor-facing information products.

Broad incumbents

• Wolters Kluwer Health: Global medical publisher offering Lippincott clinical journals, clinical decision tools, and professional healthcare content. Comparable as a broad incumbent publishing clinical and medical journals with subscription and institutional access models targeting clinical research and healthcare professionals.
• Informa Pharma Intelligence: Global provider of clinical trial intelligence, drug development data, and industry publications including trade journals for clinical research professionals. Comparable as a broad incumbent publishing clinical research industry content, trial databases, and professional intelligence products.
• Springer Nature: Global STM publisher producing thousands of peer-reviewed scientific and medical journals including clinical research titles. Comparable as a broad incumbent in scientific/medical publishing with subscription journals, databases, and professional content for clinical researchers.
• Elsevier (RELX): Global publisher of scientific, technical, and medical journals including clinical research titles, plus research databases and clinical decision tools. Comparable as a broad incumbent in STM publishing with extensive clinical journals and database products serving the clinical research community.

Emerging players

• DIA Global: Global nonprofit association for life sciences professionals producing conferences, training, publications, and regulatory intelligence. Comparable as an emerging peer operating in clinical research professional education, content, and community platforms with overlapping audience.

Regional players

• Via Medica: Polish medical publisher producing peer-reviewed clinical journals and educational content for Polish healthcare professionals. Comparable as a regional peer operating in Polish-language medical/clinical publishing with subscription-based journal offerings targeting clinicians and researchers in Poland.
• Index Copernicus: Polish scientific publisher and journal evaluation platform providing indexing, journal metrics, and publishing services for Polish and Central European scientific journals. Comparable as a regional peer in Polish scholarly/medical publishing ecosystem with adjacent services to journal publishers.
• Termedia Wydawnictwo: Polish medical publishing house producing clinical and scientific journals, books, and conference materials. Comparable as a regional peer in Polish medical/scholarly publishing with subscription and open-access journal models serving Polish healthcare professionals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/badania-kliniczne

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RD Badania Kliniczne Sp. z o.o.